Hooman Khorasani, MD
- ASSOCIATE CLINICAL PROFESSOR | Dermatology
- Hospital Affiliation
- The Mount Sinai Hospital
- Dermatology Associates 212-241-9728212-241-9728
Dr. Khorasani is the Chief of the Division of Dermatologic and Cosmetic Surgery at Mount Sinai School of Medicine and a double board certified, fellowship-trained skin cancer and cosmetic surgeon. He is a diplomat of the American Board of Dermatology (Procedural Dermatology) and the American Board of Cosmetic Surgery (Dermatologic Cosmetic Surgery). https://www.drkhorasani.com/
Dr. Khorasani has specialized training in advanced skin cancer screening and management (Melanoma, Basal & Squamous Cell Carcinomas). He is an expert in Mohs micrographic surgery and post Mohs reconstructive surgery. As one of the co-founders of the Tisch Cancer Institute’s Melanoma and Skin Cancer Center, Dr. Khorasani is actively involved with clinical trials and the advancement of skin cancer therapy.
Dr. Khorasani is also a fellowship-trained cosmetic surgeon that performs cosmetic procedures including liposuction, various laser procedures, scar revisions, blepharoplasty (eye lift), Botox™, filler and fat injections.
He is deeply involved in minimal scar wound repair research and has done extensive research in this area. He is currently conducting two clinical trials addressing improved scarring after surgery.
As the co-director of the Mohs/Procedural Dermatology fellowship and the Director of Dermatologic Surgery Education at the Mount Sinai School of Medicine, Dr. Khorasani is actively involved in teaching surgical and cosmetic procedures to residents and fellows from all over the world.
Dr. Khorasani is the Chair of the Mount Sinai Spring Symposium "Advances in Facial Reconstruction & Cosmetic Surgery," a national, multi-specialty reconstructive and cosmetic cadaver workshop.
Dr. Khorasani graduated summa cum laude from UCLA with a degree in Physiological Sciences and graduated in the top 5% of his medical school with highest distinction from the University of Southern California. Following medical school, Dr. Khorasani completed his internship in General Surgery at the USC-LA County Hospital, gaining extensive exposure to trauma and reconstructive surgery. He then completed a research fellowship in Plastic Surgery at the University of Southern California School of Medicine where he studied minimal scar wound repair.
Dr. Khorasani served as chief resident and completed his dermatology residency at NYMC Metropolitan Hospital and Montefiore North in New York City. After his residency, Dr. Khorasani completed a fellowship in Procedural Dermatology and Mohs micrographic surgery at The Mount Sinai Medical Center where he had additional training in skin cancer surgery, reconstructive surgery and cosmetic surgery.
Dr. Khorasani is a member of the Alpha Omega Alpha Honor Medical Society, American Society of Dermatologic Surgery, American Academy of Dermatology and American College of Mohs Micrographic Surgery and Cutaneous Oncology.
TV Video Links
- Dr Khorasani interviewed by ABC News about skin cancers in skin of color
- Dr Khorasani interviewed by ABC News about Melanoma
- Daily News article about one of the largest skin cancers treated by Dr. Khorasani
- Daily News article interviewing Dr. Khorasani about the rise in Melanoma
- CBS News article about tattoos on birthmarks
- Healthline interviewing Dr. Khorasani about facial thermal scanning
- Boston Globe Interviewing Dr. Khorasani about dangers of tanning salons
- Yahoo Health Interviewing Dr. Khorasani and one of his melanoma patients
American Board of Cosmetic Surgery
American Board of Dermatology
- Acne Scars
- Actinic Keratosis
- Age Spots
- Aging Skin
- Basal Cell Carcinoma
- Botulinum Injections - Cosmetic
- Broken Blood Vessels
- Cosmetic Surgery
- Dysplastic Nevus
- Frown Lines
- Hyperpigmentation Submental Fullness
- Laceration Repair
- Laser Resurfacing
- Laser Surgery
- Lip Lines
- Melanoma Removal
- Mohs Micrographic Surgery
- Mohs Surgery
- Non-melanoma Skin Cancer
- Pigmentary Disorders
- Reconstructive Surgery
- Skin Cancer
- Skin Discoloration
- Skin Graft
- Skin Lesion Removal
- Skin check
- Squamous Cell
- Squamous Cell Carcinoma
- Subcutaneous Injection
- Sun Damage
- Sun-Damaged Skin
- Vascular Birthmarks
MD, University of Southern California
Residency, General Surgery
University of Southern California Hospital
Fellowship, Procedural Dermatology/Mohs
Mount Sinai Hospital
Teacher of The Year 2011
Mount Sinai School of Medicine Dep. of Dermatology
For Excellence in Resident and Fellow Teaching
Minimal Scar Wound Repair
Intensely interested in minimal scar wound repair, he has done extensive research in this area. In particular, he has focused on the molecular agents involved in fetal scarless wound healing including TGF family of molecules and Fibromodulin. Dr. Khorasani has presented his work at multiple national meetings.
Scar analysis of post Mohs micrographic surgery wounds treated with ablative C02 resurfacing
Using fractal analysis and lacunarity to objectively analyze wounds treated with ablative fractional CO2 laser post surgery.
Khorasani H, Zheng Z, Nguyen C, Zara J, Zhang X, Wang J, Ting K, Soo C. A quantitative approach to scar analysis. The American journal of pathology 2011 Feb; 178(2).
Zheng Z, Nguyen C, Zhang X, Khorasani H, Wang JZ, Zara JN, Chu F, Yin W, Pang S, Le A, Ting K, Soo C. Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-β3 signaling. The Journal of investigative dermatology 2011 Mar; 131(3).
Chotiner JK, Khorasani H, Nairn AC, O'Dell TJ, Watson JB. Adenylyl cyclase-dependent form of chemical long-term potentiation triggers translational regulation at the elongation step. Neuroscience 2003; 116(3).
Watson JB, Khorasani H, Persson A, Huang KP, Huang FL, O'Dell TJ. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. Journal of neuroscience research 2002 Nov; 70(3).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Khorasani did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.